NL-OMON48001撤回2 期
The treatment of breast cancer with thermal ablation: a pilot study - THERMAC
Franciscus Ziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •2. Pathologically confirmed unifocal primary invasive breast cancer, unilateral
- •3. A clinical T1 tumor (<2cm on US and/or MRI), without distant metastases. The
- •largest dimension measured will be used to determine eligibility.
- •4. Tumor should be visible on ultrasound
- •5. Aged 18 years or older
- •6. Component DCIS < 25% on MRI as a total of the tumor
- •7. Written informed consent
排除标准
- •1. History of invasive breast cancer
- •2. Pregnant or nursing
- •3. BRCA 1 or 2 positive (if known)
- •4. Breast augmentation
- •5. Electrical devices and/or implants
- •6. Neoadjuvant chemotherapy
- •7. Triple negative tumors, Her2neu overexpression, Elston/Nottingham grade 3,
- •lobular carcinoma
- •8. Allergic to local anaesthetics
研究者
相似试验
招募中
2 期
The Treatment of Breast Cancer with PercutaneousThermal Ablation: A phase 2 screening trialbreast neoplasms100062911000623210006295breast cancerNL-OMON49602Franciscus Ziekenhuis63
已完成
不适用
Treatment of breast cancer-associated lymphedema. A randomized study of the (cost-)effectiveness of manual lymphatic drainage and/or intermittent pneumatic compressioLymphedema100062911004079510025231NL-OMON30736Academisch Ziekenhuis Maastricht207
尚未招募
不适用
Advanced Radiotherapy in Carcinoma Breast.CTRI/2019/11/022151Kasturba Medical College Manipal
进行中（未招募）
1 期
Cyclophosphamide chemotherapy for breast cancers harboring TP53 gene mutationsocally advanced breast cancer and metastatic breast cancerEUCTR2016-003459-31-NOHelse Bergen, Haukeland University Hospital190
进行中（未招募）
1 期
A study investigating the use of additional chemotherapy for the improvement of efficacy, and the selection of breast cancer patients for such treatment in two paitent cohorts: Before surgery in curable patients and at time of metastatic disease.breast cancerEUCTR2013-004418-17-NOOslo University Hospital